Paul R Lichter

Author PubWeight™ 38.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005 2.32
2 Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology 2008 2.20
3 Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet 2005 2.20
4 Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet 2012 2.00
5 Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 2009 1.83
6 Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011 1.70
7 Assessing the need for posterior sclerotomy at the time of filtering surgery in patients with Sturge-Weber syndrome. Ophthalmology 2003 1.63
8 Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2005 1.53
9 Racial disparities in the use of ancillary testing to evaluate individuals with open-angle glaucoma. Arch Ophthalmol 2012 1.46
10 Normal-tension glaucoma history. Ophthalmology 2002 1.39
11 The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci 2003 1.20
12 Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology 2006 1.17
13 Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol 2007 1.12
14 Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol 2006 1.08
15 Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2007 1.07
16 The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables. J Glaucoma 2013 1.06
17 Trends in use of ancillary glaucoma tests for patients with open-angle glaucoma from 2001 to 2009. Ophthalmology 2012 0.98
18 Genome-wide association study and meta-analysis of intraocular pressure. Hum Genet 2013 0.98
19 Fear of blindness in the Collaborative Initial Glaucoma Treatment Study: patterns and correlates over time. Ophthalmology 2007 0.94
20 Variation in optineurin (OPTN) allele frequencies between and within populations. Mol Vis 2007 0.94
21 GALC deletions increase the risk of primary open-angle glaucoma: the role of Mendelian variants in complex disease. PLoS One 2011 0.94
22 Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 2012 0.93
23 Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma. Hum Genet 2014 0.93
24 Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States. Mol Vis 2013 0.90
25 Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds. Mol Vis 2007 0.88
26 Expectations from clinical trials: results of the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002 0.85
27 CDKN2B-AS1 genotype-glaucoma feature correlations in primary open-angle glaucoma patients from the United States. Am J Ophthalmol 2012 0.83
28 Ordered subset analysis supports a glaucoma locus at GLC1I on chromosome 15 in families with earlier adult age at diagnosis. Exp Eye Res 2005 0.82
29 Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study. Br J Ophthalmol 2012 0.78
30 Converting to SITA-standard from full-threshold visual field testing in the follow-up phase of a clinical trial. Invest Ophthalmol Vis Sci 2005 0.78
31 Association between the use of glaucoma medications and mortality. Arch Ophthalmol 2010 0.77
32 Cost-effectiveness. Ophthalmology 2008 0.75
33 Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell? Arch Ophthalmol 2008 0.75
34 A perspective on commercial relationships between ophthalmology and industry. Arch Ophthalmol 2009 0.75
35 Interview with Paul R. Lichter, MD. Interwed by George B Bartley. Arch Ophthalmol 2012 0.75
36 Septuagenarian's phenotype leads to ascertainment of familial MYOC gene mutation. J Glaucoma 2003 0.75
37 Robert N. Shaffer. Am J Ophthalmol 2008 0.75